Ginkgo biloba modulates ET-I/NO signalling in Lead Acetate induced rat model of endothelial dysfunction: Involvement of oxido-inflammatory mediators

Int J Environ Health Res. 2024 Feb;34(2):979-990. doi: 10.1080/09603123.2023.2194612. Epub 2023 Mar 24.

Abstract

This study investigated the modulatory effect of Ginkgo biloba extract on lead acetate-induced endothelial dysfunction. Animals were administered GBE (50 mg/kg and 100 mg/kg orally) after exposures to lead acetate (25 mg/kg orally) for 14 days. Aorta was harvested after euthanasia, the tissue was homogenised, and supernatants were decanted after centrifuging. Oxidative, nitrergic, inflammatory, and anti-apoptotic markers were assayed using standard biochemical procedure, ELISA, and immunohistochemistry, respectively. GBE reduced lead-induced oxidative stress by increasing SOD, GSH, and CAT as well as reducing MDA levels in endothelium. Pro-inflammatory cytokines (TNF-α and IL-6) were reduced while increasing Bcl-2 protein expression. GBE lowered endothelin-I and raised nitrite levels. Histological changes caused by lead acetate were normalised by GBE. Our findings suggest that Ginkgo biloba extract restored endothelin-I and nitric oxide functions by increasing Bcl-2 protein expression and reducing oxido-inflammatory stress in endothelium.

Keywords: Ginkgo biloba; apoptosis; endothelial dysfunction; lead acetate; oxido-inflammatory stress.

MeSH terms

  • Acetates
  • Animals
  • Endothelins
  • Ginkgo Extract*
  • Ginkgo biloba*
  • Lead*
  • Plant Extracts / pharmacology
  • Proto-Oncogene Proteins c-bcl-2
  • Rats

Substances

  • Ginkgo biloba extract
  • Lead
  • Plant Extracts
  • Endothelins
  • Proto-Oncogene Proteins c-bcl-2
  • Acetates
  • Ginkgo Extract